Bill Text: IA HSB642 | 2023-2024 | 90th General Assembly | Introduced
Bill Title: A bill for an act relating to self-administered hormonal contraceptives.(See HF 2584.)
Spectrum: Committee Bill
Status: (Introduced - Dead) 2024-02-19 - Committee report approving bill, renumbered as HF 2584. [HSB642 Detail]
Download: Iowa-2023-HSB642-Introduced.html
House
Study
Bill
642
-
Introduced
SENATE/HOUSE
FILE
_____
BY
(PROPOSED
GOVERNOR
BILL)
A
BILL
FOR
An
Act
relating
to
self-administered
hormonal
contraceptives.
1
BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
2
TLSB
5028XL
(3)
90
pf/ko
S.F.
_____
H.F.
_____
Section
1.
NEW
SECTION
.
155A.49
Pharmacist
dispensing
of
1
self-administered
hormonal
contraceptives
——
standing
order
——
2
requirements
——
limitations
of
liability.
3
1.
a.
Notwithstanding
any
provision
of
law
to
the
contrary,
4
a
pharmacist
may
dispense
a
self-administered
hormonal
5
contraceptive
to
a
patient
who
is
at
least
eighteen
years
of
6
age,
pursuant
to
a
standing
order
established
by
the
medical
7
director
of
the
department
in
accordance
with
this
section.
8
b.
In
dispensing
a
self-administered
hormonal
contraceptive
9
to
a
patient
under
this
section,
a
pharmacist
shall
comply
with
10
all
of
the
following:
11
(1)
For
an
initial
dispensing
of
a
self-administered
12
hormonal
contraceptive,
the
pharmacist
may
dispense
only
up
13
to
a
three-month
supply
at
one
time
of
the
self-administered
14
hormonal
contraceptive.
15
(2)
For
any
subsequent
dispensing
of
the
same
16
self-administered
hormonal
contraceptive,
the
pharmacist
17
may
dispense
up
to
a
twelve-month
supply
at
one
time
of
the
18
self-administered
hormonal
contraceptive.
19
2.
A
pharmacist
who
dispenses
a
self-administered
hormonal
20
contraceptive
in
accordance
with
this
section
shall
not
21
require
any
other
prescription
drug
order
authorized
by
a
22
practitioner
prior
to
dispensing
the
self-administered
hormonal
23
contraceptive
to
a
patient.
24
3.
The
medical
director
of
the
department
may
establish
a
25
standing
order
authorizing
the
dispensing
of
self-administered
26
hormonal
contraceptives
by
a
pharmacist
who
does
all
of
the
27
following:
28
a.
Complies
with
the
standing
order
established
pursuant
to
29
this
section.
30
b.
Retains
a
record
of
each
patient
to
whom
a
31
self-administered
hormonal
contraceptive
is
dispensed
under
32
this
section
and
submits
the
record
to
the
department.
33
4.
The
standing
order
shall
require
a
pharmacist
who
34
dispenses
self-administered
hormonal
contraceptives
under
this
35
-1-
LSB
5028XL
(3)
90
pf/ko
1/
11
S.F.
_____
H.F.
_____
section
to
do
all
of
the
following:
1
a.
Complete
a
standardized
training
program
and
continuing
2
education
requirements
approved
by
the
board
in
consultation
3
with
the
board
of
medicine
and
the
department
that
are
related
4
to
prescribing
self-administered
hormonal
contraceptives
and
5
include
education
regarding
all
contraceptive
methods
approved
6
by
the
United
States
food
and
drug
administration.
7
b.
Obtain
a
completed
self-screening
risk
assessment,
8
approved
by
the
department
in
collaboration
with
the
board
and
9
the
board
of
medicine,
from
each
patient,
verify
the
identity
10
and
age
of
each
patient,
and
perform
a
blood
pressure
screening
11
on
each
patient
prior
to
dispensing
the
self-administered
12
hormonal
contraceptive
to
the
patient.
13
c.
Provide
the
patient
with
all
of
the
following:
14
(1)
Written
information
regarding
all
of
the
following:
15
(a)
The
importance
of
completing
an
appointment
with
the
16
patient’s
primary
care
or
women’s
health
care
practitioner
17
to
obtain
preventative
care,
including
but
not
limited
to
18
recommended
tests
and
screenings.
19
(b)
The
effectiveness
and
availability
of
long-acting
20
reversible
contraceptives
as
an
alternative
to
21
self-administered
hormonal
contraceptives.
22
(2)
A
copy
of
the
record
of
the
pharmacist’s
encounter
with
23
the
patient
that
includes
all
of
the
following:
24
(a)
The
patient’s
completed
self-screening
risk
assessment.
25
(b)
A
description
of
the
contraceptive
dispensed,
or
the
26
basis
for
not
dispensing
a
contraceptive.
27
(3)
Patient
counseling
regarding
all
of
the
following:
28
(a)
The
appropriate
administration
and
storage
of
the
29
self-administered
hormonal
contraceptive.
30
(b)
Potential
side
effects
and
risks
of
the
31
self-administered
hormonal
contraceptive.
32
(c)
The
need
for
backup
contraception.
33
(d)
When
to
seek
emergency
medical
attention.
34
(e)
The
risk
of
contracting
a
sexually
transmitted
35
-2-
LSB
5028XL
(3)
90
pf/ko
2/
11
S.F.
_____
H.F.
_____
infection
or
disease,
and
ways
to
reduce
such
a
risk.
1
5.
The
standing
order
established
pursuant
to
this
section
2
shall
prohibit
a
pharmacist
who
dispenses
a
self-administered
3
hormonal
contraceptive
under
this
section
from
doing
any
of
the
4
following:
5
a.
Requiring
a
patient
to
schedule
an
appointment
with
6
the
pharmacist
for
the
prescribing
or
dispensing
of
a
7
self-administered
hormonal
contraceptive.
8
b.
Dispensing
self-administered
hormonal
contraceptives
9
to
a
patient
for
more
than
twenty-seven
months
after
the
10
date
a
self-administered
hormonal
contraceptive
is
initially
11
dispensed
to
the
patient,
if
the
patient
has
not
consulted
with
12
a
primary
care
or
women’s
health
care
practitioner
during
the
13
preceding
twenty-seven
months,
in
which
case
the
pharmacist
14
shall
refer
the
patient
to
a
primary
care
or
women’s
health
15
care
practitioner.
16
c.
Dispensing
a
self-administered
hormonal
contraceptive
to
17
a
patient
if
the
results
of
the
self-screening
risk
assessment
18
completed
by
a
patient
pursuant
to
subsection
4,
paragraph
19
“b”
,
indicate
it
is
unsafe
for
the
pharmacist
to
dispense
the
20
self-administered
hormonal
contraceptive
to
the
patient,
in
21
which
case
the
pharmacist
shall
refer
the
patient
to
a
primary
22
care
or
women’s
health
care
practitioner.
23
6.
A
pharmacist
who
dispenses
a
self-administered
hormonal
24
contraceptive
and
the
medical
director
of
the
department
who
25
establishes
a
standing
order
in
compliance
with
this
section
26
shall
be
immune
from
criminal
and
civil
liability
arising
27
from
any
damages
caused
by
the
dispensing,
administering,
28
or
use
of
a
self-administered
hormonal
contraceptive
or
the
29
establishment
of
the
standing
order.
The
medical
director
of
30
the
department
shall
be
considered
to
be
acting
within
the
31
scope
of
the
medical
director’s
office
and
employment
for
32
purposes
of
chapter
669
in
the
establishment
of
a
standing
33
order
in
compliance
with
this
section.
34
7.
The
department,
in
collaboration
with
the
board
and
35
-3-
LSB
5028XL
(3)
90
pf/ko
3/
11
S.F.
_____
H.F.
_____
the
board
of
medicine,
and
in
consideration
of
the
guidelines
1
established
by
the
American
congress
of
obstetricians
and
2
gynecologists,
shall
adopt
rules
pursuant
to
chapter
17A
to
3
administer
this
chapter.
4
8.
As
used
in
this
section:
5
a.
“Department”
means
the
department
of
health
and
human
6
services.
7
b.
“Self-administered
hormonal
contraceptive”
means
a
8
self-administered
hormonal
contraceptive
that
is
approved
by
9
the
United
States
food
and
drug
administration
to
prevent
10
pregnancy.
“Self-administered
hormonal
contraceptive”
includes
11
an
oral
hormonal
contraceptive,
a
hormonal
vaginal
ring,
and
12
a
hormonal
contraceptive
patch,
but
does
not
include
any
drug
13
intended
to
induce
an
abortion
as
defined
in
section
146.1.
14
c.
“Standing
order”
means
a
preauthorized
medication
order
15
with
specific
instructions
from
the
medical
director
of
the
16
department
to
dispense
a
medication
under
clearly
defined
17
circumstances.
18
Sec.
2.
Section
514C.19,
Code
2024,
is
amended
to
read
as
19
follows:
20
514C.19
Prescription
contraceptive
coverage.
21
1.
Notwithstanding
the
uniformity
of
treatment
requirements
22
of
section
514C.6
,
a
group
policy
,
or
contract
,
or
plan
23
providing
for
third-party
payment
or
prepayment
of
health
or
24
medical
expenses
shall
not
do
either
of
the
following
comply
25
as
follows
:
26
a.
Exclude
Such
policy,
contract,
or
plan
shall
not
27
exclude
or
restrict
benefits
for
prescription
contraceptive
28
drugs
or
prescription
contraceptive
devices
which
prevent
29
conception
and
which
are
approved
by
the
United
States
30
food
and
drug
administration,
or
generic
equivalents
31
approved
as
substitutable
by
the
United
States
food
and
32
drug
administration,
if
such
policy
,
or
contract
,
or
plan
33
provides
benefits
for
other
outpatient
prescription
drugs
34
or
devices.
However,
such
policy,
contract,
or
plan
shall
35
-4-
LSB
5028XL
(3)
90
pf/ko
4/
11
S.F.
_____
H.F.
_____
specifically
provide
for
payment
of
a
self-administered
1
hormonal
contraceptive,
as
prescribed
by
a
practitioner
as
2
defined
in
section
155A.3,
or
as
prescribed
by
standing
order
3
and
dispensed
by
a
pharmacist
pursuant
to
section
155A.49,
4
including
payment
for
up
to
an
initial
three-month
supply
5
of
a
self-administered
hormonal
contraceptive
dispensed
at
6
one
time
and
for
up
to
a
twelve-month
supply
of
the
same
7
self-administered
hormonal
contraceptive
subsequently
dispensed
8
at
one
time.
9
b.
Exclude
Such
policy,
contract,
or
plan
shall
not
exclude
10
or
restrict
benefits
for
outpatient
contraceptive
services
11
which
are
provided
for
the
purpose
of
preventing
conception
if
12
such
policy
,
or
contract
,
or
plan
provides
benefits
for
other
13
outpatient
services
provided
by
a
health
care
professional.
14
2.
A
person
who
provides
a
group
policy
,
or
contract
,
or
15
plan
providing
for
third-party
payment
or
prepayment
of
health
16
or
medical
expenses
which
is
subject
to
subsection
1
shall
not
17
do
any
of
the
following:
18
a.
Deny
to
an
individual
eligibility,
or
continued
19
eligibility,
to
enroll
in
or
to
renew
coverage
under
the
terms
20
of
the
policy
,
or
contract
,
or
plan
because
of
the
individual’s
21
use
or
potential
use
of
such
prescription
contraceptive
drugs
22
or
devices,
or
use
or
potential
use
of
outpatient
contraceptive
23
services.
24
b.
Provide
a
monetary
payment
or
rebate
to
a
covered
25
individual
to
encourage
such
individual
to
accept
less
than
the
26
minimum
benefits
provided
for
under
subsection
1
.
27
c.
Penalize
or
otherwise
reduce
or
limit
the
reimbursement
28
of
a
health
care
professional
because
such
professional
29
prescribes
contraceptive
drugs
or
devices,
or
provides
30
contraceptive
services.
31
d.
Provide
incentives,
monetary
or
otherwise,
to
a
health
32
care
professional
to
induce
such
professional
to
withhold
33
from
a
covered
individual
contraceptive
drugs
or
devices,
or
34
contraceptive
services.
35
-5-
LSB
5028XL
(3)
90
pf/ko
5/
11
S.F.
_____
H.F.
_____
3.
This
section
shall
not
be
construed
to
prevent
a
1
third-party
payor
from
including
deductibles,
coinsurance,
or
2
copayments
under
the
policy
,
or
contract,
or
plan
as
follows:
3
a.
A
deductible,
coinsurance,
or
copayment
for
benefits
4
for
prescription
contraceptive
drugs
shall
not
be
greater
than
5
such
deductible,
coinsurance,
or
copayment
for
any
outpatient
6
prescription
drug
for
which
coverage
under
the
policy
,
or
7
contract
,
or
plan
is
provided.
8
b.
A
deductible,
coinsurance,
or
copayment
for
benefits
for
9
prescription
contraceptive
devices
shall
not
be
greater
than
10
such
deductible,
coinsurance,
or
copayment
for
any
outpatient
11
prescription
device
for
which
coverage
under
the
policy
,
or
12
contract
,
or
plan
is
provided.
13
c.
A
deductible,
coinsurance,
or
copayment
for
benefits
for
14
outpatient
contraceptive
services
shall
not
be
greater
than
15
such
deductible,
coinsurance,
or
copayment
for
any
outpatient
16
health
care
services
for
which
coverage
under
the
policy
,
or
17
contract
,
or
plan
is
provided.
18
4.
This
section
shall
not
be
construed
to
require
a
19
third-party
payor
under
a
policy
,
or
contract
,
or
plan
20
to
provide
benefits
for
experimental
or
investigational
21
contraceptive
drugs
or
devices,
or
experimental
or
22
investigational
contraceptive
services,
except
to
the
extent
23
that
such
policy
,
or
contract
,
or
plan
provides
coverage
for
24
other
experimental
or
investigational
outpatient
prescription
25
drugs
or
devices,
or
experimental
or
investigational
outpatient
26
health
care
services.
27
5.
This
section
shall
not
be
construed
to
limit
or
otherwise
28
discourage
the
use
of
generic
equivalent
drugs
approved
by
the
29
United
States
food
and
drug
administration,
whenever
available
30
and
appropriate.
This
section
,
when
a
brand
name
drug
is
31
requested
by
a
covered
individual
and
a
suitable
generic
32
equivalent
is
available
and
appropriate,
shall
not
be
construed
33
to
prohibit
a
third-party
payor
from
requiring
the
covered
34
individual
to
pay
a
deductible,
coinsurance,
or
copayment
35
-6-
LSB
5028XL
(3)
90
pf/ko
6/
11
S.F.
_____
H.F.
_____
consistent
with
subsection
3
,
in
addition
to
the
difference
of
1
the
cost
of
the
brand
name
drug
less
the
maximum
covered
amount
2
for
a
generic
equivalent.
3
6.
A
person
who
provides
an
individual
policy
,
or
contract
,
4
or
plan
providing
for
third-party
payment
or
prepayment
of
5
health
or
medical
expenses
shall
make
available
a
coverage
6
provision
that
satisfies
the
requirements
in
subsections
7
1
through
5
in
the
same
manner
as
such
requirements
are
8
applicable
to
a
group
policy
,
or
contract
,
or
plan
under
those
9
subsections.
The
policy
,
or
contract
,
or
plan
shall
provide
10
that
the
individual
policyholder
may
reject
the
coverage
11
provision
at
the
option
of
the
policyholder.
12
7.
a.
This
section
applies
to
the
following
classes
of
13
third-party
payment
provider
contracts
,
or
policies
,
or
plans
14
delivered,
issued
for
delivery,
continued,
or
renewed
in
this
15
state
on
or
after
July
1,
2000
January
1,
2025
:
16
(1)
Individual
or
group
accident
and
sickness
insurance
17
providing
coverage
on
an
expense-incurred
basis.
18
(2)
An
individual
or
group
hospital
or
medical
service
19
contract
issued
pursuant
to
chapter
509
,
514
,
or
514A
.
20
(3)
An
individual
or
group
health
maintenance
organization
21
contract
regulated
under
chapter
514B
.
22
(4)
Any
other
entity
engaged
in
the
business
of
insurance,
23
risk
transfer,
or
risk
retention,
which
is
subject
to
the
24
jurisdiction
of
the
commissioner.
25
(5)
A
plan
established
pursuant
to
chapter
509A
for
public
26
employees.
27
b.
This
section
shall
not
apply
to
accident-only,
28
specified
disease,
short-term
hospital
or
medical,
hospital
29
confinement
indemnity,
credit,
dental,
vision,
Medicare
30
supplement,
long-term
care,
basic
hospital
and
medical-surgical
31
expense
coverage
as
defined
by
the
commissioner,
disability
32
income
insurance
coverage,
coverage
issued
as
a
supplement
33
to
liability
insurance,
workers’
compensation
or
similar
34
insurance,
or
automobile
medical
payment
insurance.
35
-7-
LSB
5028XL
(3)
90
pf/ko
7/
11
S.F.
_____
H.F.
_____
8.
This
section
shall
not
be
construed
to
require
a
1
third-party
payor
under
a
policy,
contract,
or
plan
to
2
provide
payment
to
a
practitioner
for
the
dispensing
of
3
a
self-administered
hormonal
contraceptive
to
replace
a
4
self-administered
hormonal
contraceptive
that
has
been
5
dispensed
to
a
covered
person
and
that
has
been
misplaced,
6
stolen,
or
destroyed.
This
section
shall
not
be
construed
to
7
require
a
third-party
payor
under
a
policy,
contract,
or
plan
8
to
replace
covered
prescriptions
that
are
misplaced,
stolen,
9
or
destroyed.
10
9.
For
the
purposes
of
this
section,
“self-administered
11
hormonal
contraceptive”
and
“standing
order”
mean
the
same
as
12
defined
in
section
155A.49.
13
Sec.
3.
INFORMATION
PROGRAM
FOR
DRUG
PRESCRIBING
AND
14
DISPENSING
——
SELF-ADMINISTERED
HORMONAL
CONTRACEPTIVES.
The
15
board
of
pharmacy
in
collaboration
with
the
board
of
medicine
16
and
the
department
of
health
and
human
services
shall
expand
17
the
information
program
for
drug
prescribing
and
dispensing
18
established
pursuant
to
section
124.551,
to
collect
from
19
pharmacists
information
relating
to
the
dispensing
of
20
self-administered
hormonal
contraceptives
as
provided
pursuant
21
to
section
155A.49.
The
board
of
pharmacy
shall
adopt
22
rules
pursuant
to
chapter
17A
related
to
registration
of
23
participating
pharmacists,
the
information
to
be
reported
by
a
24
pharmacist
to
the
information
program,
access
to
information
25
from
the
program,
and
other
rules
necessary
to
carry
out
the
26
purposes
and
to
enforce
the
provisions
of
this
section.
27
Sec.
4.
APPLICATION
TO
MEDICAID
PROGRAM.
This
Act
shall
28
apply
to
the
Medicaid
program
including
a
managed
care
29
organization
acting
pursuant
to
a
contract
with
the
department
30
of
health
and
human
services
to
administer
the
Medicaid
program
31
under
chapter
249A.
However,
if
it
is
determined
that
any
32
provision
of
this
Act
would
cause
denial
of
federal
funds
under
33
Tit.
XVIII
or
XIX
of
the
federal
Social
Security
Act,
or
would
34
otherwise
be
inconsistent
or
conflict
with
the
requirements
of
35
-8-
LSB
5028XL
(3)
90
pf/ko
8/
11
S.F.
_____
H.F.
_____
federal
law
or
regulation,
such
provision
shall
be
suspended,
1
but
only
to
the
extent
necessary
to
prevent
denial
of
such
2
funds
or
to
eliminate
the
inconsistency
or
conflict
with
the
3
requirements
of
federal
law
or
regulation.
4
EXPLANATION
5
The
inclusion
of
this
explanation
does
not
constitute
agreement
with
6
the
explanation’s
substance
by
the
members
of
the
general
assembly.
7
This
bill
relates
to
the
dispensing
of
self-administered
8
hormonal
contraceptives
by
a
pharmacist.
The
bill
9
defines
“self-administered
hormonal
contraceptive”
as
a
10
self-administered
hormonal
contraceptive
that
is
approved
by
11
the
United
States
food
and
drug
administration
to
prevent
12
pregnancy,
including
an
oral
hormonal
contraceptive,
a
hormonal
13
vaginal
ring,
and
a
hormonal
contraceptive
patch,
but
not
14
including
any
drug
intended
to
induce
an
abortion.
15
The
bill
provides
that
notwithstanding
any
provision
of
law
16
to
the
contrary,
a
pharmacist
may
dispense
a
self-administered
17
hormonal
contraceptive
to
a
patient
who
is
at
least
18
18
years
of
age
pursuant
to
a
standing
order
established
by
the
19
medical
director
(medical
director)
of
the
department
of
20
health
and
human
services
(HHS).
For
an
initial
dispensing,
21
a
pharmacist
may
dispense
only
up
to
a
three-month
supply
at
22
one
time
of
the
self-administered
hormonal
contraceptive,
and
23
for
any
subsequent
dispensing
of
the
same
self-administered
24
hormonal
contraceptive,
a
12-month
supply
at
one
time.
25
Additionally,
the
bill
prohibits
a
pharmacist
who
dispenses
26
a
self-administered
hormonal
contraceptive
in
accordance
27
with
the
bill
from
requiring
any
other
prescription
drug
28
order
authorized
by
a
practitioner
prior
to
dispensing
the
29
self-administered
hormonal
contraceptive.
30
The
bill
authorizes
the
medical
director
to
establish
a
31
standing
order
authorizing
the
dispensing
of
self-administered
32
hormonal
contraceptives
by
any
pharmacist
who
complies
with
the
33
standing
order
and
retains
and
submits
the
patient’s
record
to
34
HHS.
35
-9-
LSB
5028XL
(3)
90
pf/ko
9/
11
S.F.
_____
H.F.
_____
The
standing
order
includes
requiring
a
pharmacist
who
1
dispenses
a
self-administered
hormonal
contraceptive
under
2
the
bill
to:
complete
a
standardized
training
program
and
3
continuing
education
requirements
related
to
prescribing
the
4
hormonal
contraceptives;
obtain
a
completed
self-screening
risk
5
assessment
from
each
patient,
verify
the
identity
and
age
of
6
each
patient,
and
perform
a
blood
pressure
screening
on
each
7
patient
before
dispensing
the
hormonal
contraceptives;
provide
8
the
patient
with
certain
written
information;
provide
the
9
patient
with
a
copy
of
the
record
of
the
pharmacist’s
encounter
10
with
the
patient;
and
provide
patient
counseling.
11
The
standing
order
would
prohibit
a
pharmacist
who
dispenses
12
hormonal
contraceptives
under
the
bill
from
requiring
a
13
patient
to
schedule
an
appointment
with
the
pharmacist
for
14
the
prescribing
or
dispensing
of
the
hormonal
contraceptives;
15
dispensing
the
hormonal
contraceptives
to
a
patient
for
more
16
than
27
months
after
the
date
initially
dispensed
without
the
17
patient’s
attestation
that
the
patient
has
consulted
with
a
18
practitioner
during
the
preceding
27
months;
and
dispensing
19
the
hormonal
contraceptives
to
a
patient
if
the
results
of
the
20
patient’s
self-screening
risk
assessment
indicate
it
is
unsafe
21
for
the
pharmacist
to
dispense
the
hormonal
contraceptives
22
to
the
patient,
in
which
case
the
pharmacist
shall
refer
the
23
patient
to
a
practitioner.
24
The
bill
provides
immunity
for
a
pharmacist
who
dispenses
a
25
self-administered
hormonal
contraceptive
and
for
the
medical
26
director
who
establishes
a
standing
order
in
compliance
with
27
the
bill
from
criminal
and
civil
liability
arising
from
any
28
damages
caused
by
the
dispensing,
administering,
or
use
of
a
29
self-administered
hormonal
contraceptive
or
the
establishment
30
of
the
standing
order.
Additionally,
the
medical
director
31
shall
be
considered
to
be
acting
within
the
scope
of
the
32
medical
director’s
office
and
employment
for
purposes
of
Code
33
chapter
669
(Iowa
tort
claims
Act)
in
the
establishment
of
a
34
standing
order
in
compliance
with
the
bill.
35
-10-
LSB
5028XL
(3)
90
pf/ko
10/
11
S.F.
_____
H.F.
_____
The
bill
requires
HHS,
in
collaboration
with
the
boards
of
1
pharmacy
and
medicine,
and
in
consideration
of
the
guidelines
2
established
by
the
American
congress
of
obstetricians
and
3
gynecologists,
to
adopt
administrative
rules
to
administer
the
4
provisions
of
the
bill.
5
The
bill
amends
prescription
contraceptive
coverage
6
provisions
in
the
Code
to
require
that
a
group
policy,
7
contract,
or
plan
delivered,
issued
for
delivery,
continued,
8
or
renewed
in
the
state
on
or
after
January
1,
2025,
9
providing
for
third-party
payment
or
prepayment
of
health
or
10
medical
expenses,
shall
specifically
provide
for
payment
of
11
self-administered
hormonal
contraceptives,
prescribed
and
12
dispensed
as
specified
in
the
bill,
including
those
dispensed
13
at
one
time.
The
bill
provides,
however,
that
the
provisions
14
relating
to
coverage
are
not
to
be
construed
to
require
a
15
third-party
payor
under
a
policy,
contract,
or
plan
to
provide
16
payment
to
a
practitioner
for
dispensing
a
self-administered
17
hormonal
contraceptive
to
replace
a
self-administered
18
hormonal
contraceptive
that
has
been
dispensed
to
a
covered
19
person
and
that
has
been
misplaced,
stolen,
or
destroyed.
20
These
provisions
are
also
not
to
be
construed
to
require
a
21
third-party
payor
under
a
policy,
contract,
or
plan
to
replace
22
covered
prescriptions
that
are
misplaced,
stolen,
or
destroyed.
23
The
bill
also
requires
the
board
of
pharmacy
in
24
collaboration
with
the
board
of
medicine
and
HHS
to
expand
25
the
information
program
for
drug
prescribing
to
collect
26
from
pharmacists
information
relating
to
the
dispensing
of
27
self-administered
hormonal
contraceptives
as
provided
in
the
28
bill.
29
The
bill
applies
to
the
Medicaid
program
as
specified
in
the
30
bill.
31
-11-
LSB
5028XL
(3)
90
pf/ko
11/
11